Application of cucurbitacine E in preparation of medicine for preventing or treating adrenal cortex cancer

The invention relates to application of cucurbitacine E in preparation of a medicine for preventing or treating adrenal cortex cancer, and belongs to the technical field of medicines. The cucurbitacine E provided by the invention can inhibit proliferation of adrenal cortex cancer cells. The anti-tumor effect is achieved by inhibiting DNA replication of adrenal cortex cancer cells and retarding the cell cycle, so that cell apoptosis is induced. In addition, the cucurbitacin E can inhibit tumors by inhibiting migration and invasion of adrenal cortex cancer cells..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 03. Feb. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

WANG JINHUA [VerfasserIn]
DU GUANHUA [VerfasserIn]
REN LIWEN [VerfasserIn]
LI WAN [VerfasserIn]
FU WEIQI [VerfasserIn]
ZHENG XIANGJIN [VerfasserIn]
LIU JINYI [VerfasserIn]
LI SHA [VerfasserIn]
YANG YIHUI [VerfasserIn]
YANG HONG [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-02-03, Last update posted on www.tib.eu: 2023-06-07, Last updated: 2023-06-16

Patentnummer:

CN115671115

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA017155762